• Topical steroids

Desowen Generic Name & Formulations

General Description

Desonide 0.05%; crm.

How Supplied


Desowen Indications


Corticosteroid-responsive dermatoses.

Desowen Dosage and Administration


Apply a thin film to affected areas 2–3 times daily; discontinue when control is achieved. Do not occlude.


Not established.

Desowen Contraindications

Not Applicable

Desowen Boxed Warnings

Not Applicable

Desowen Warnings/Precautions


Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Treat infection if present; discontinue if infection persists or worsens. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Desowen Pharmacokinetics

See Literature

Desowen Interactions

Desowen Adverse Reactions

Adverse Reactions

Burning, stinging, irritation, contact dermatitis, condition worsened, skin peeling, itching, intense transient erythema, dryness/scaliness; HPA axis suppression (esp. in children).

Desowen Clinical Trials

See Literature

Desowen Note

Not Applicable

Desowen Patient Counseling

See Literature